Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants
Status:
Completed
Trial end date:
2020-03-27
Target enrollment:
Participant gender:
Summary
To provide a mechanism for critically ill infants with parenteral nutrition (PN) associated
cholestasis to receive Omegaven for compassionate use situations for which there are no
satisfactory alternative treatments.
Phase:
N/A
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
Boston Children's Hospital Boston Children’s Hospital